Skip to main content

Table 1 Baseline demographic characteristics, medications, and laboratory parameters

From: The association between diabetes coexisting with low levels of high-density lipoprotein cholesterol and peritoneal dialysis-related peritonitis

Variablesa

Total (n = 1013)

No comorbidity (n = 472)

Low HDL-C (n = 374)

DM (n = 95)

DM plus low HDL-C (n = 72)

P-value

Age (years)b

49.94 ± 14.32 (n = 1013)

47.89 ± 14.04

47.98 ± 14.20

59.67 ± 9.93

60.74 ± 11.56

 < 0.001

Male [n (%)]

597 (59.0%, n = 1013)

241(51.1%)

267 (71.4%)

51 (53.7%)

38 (53.5%)

 < 0.001

Body mass index (kg/m2)b

22.81 ± 3.23 (n = 994)

22.04 ± 2.98

23.34 ± 3.36

23.76 ± 3.14

23.91 ± 3.10

 < 0.001

Residual urine volume (mL)c

800.00 (400.00–1245.00, n = 619)

750.00 (400.00–1200.00)

810.00 (450.00–1338.75)

700.00 (487.50–1200.00)

800.00 (325.00–1045.00)

0.245

Current smoking [n (%)]

193 (19.1%, n = 1013)

72 (15.3%)

89 (23.8%)

19 (20.0%)

13 (18.1%)

0.019

Current alcohol consumption [n (%)]

71 (7.0%, n = 1013)

21 (4.5%)

39 (10.4%)

7 (7.4%)

4 (5.6%)

0.002

Pre-existing stroke [n (%)]

39 (3.9%, n = 1013)

6 (1.3%)

15 (4.0%)

9 (9.5%)

9 (12.5%)

 < 0.001

Pre-existing CVD [n (%)]

104 (10.3%, n = 1013)

21 (4.5%)

24 (6.4%)

30 (31.6%)

29 (40.3%)

 < 0.001

WBC (109/L)b

6.37 ± 2.30 (n = 1013)

5.95 ± 2.10

6.53 ± 2.53

6.80 ± 2.09

7.57 ± 2.04

 < 0.001

Hemoglobin (g/L)b

97.07 ± 23.36 (n = 1009)

97.83 ± 24.26

93.05 ± 22.67

105.35 ± 22.32

101.85 ± 17.59

 < 0.001

Serum albumin (g/L)b

34.49 ± 5.65 (n = 1008)

34.83 ± 5.38

35.06 ± 5.97

31.81 ± 4.72

32.80 ± 5.66

 < 0.001

AST (U/L)c

17.00(13.00–22.00, n = 918)

17.00 (13.00–22.00)

16.00 (12.00–22.00)

19.00 (15.50–24.50)

18.50 (14.00–24.25)

 < 0.001

ALT (U/L)c

13.00 (9.00–20.00, n = 918)

13.00 (9.00–20.00)

14.00 (8.00–20.00)

15.00 (11.00–21.00)

12.00 (8.00–16.25)

0.024

Cholesterol (mmol/L)b

4.42 ± 1.31 (n = 1009)

4.63 ± 1.25

3.92 ± 1.09

5.00 ± 1.41

4.90 ± 1.73

 < 0.001

Triglyceride (mmol/L)c

1.30 (0.94–1.88, n = 1009)

1.13 (0.82–1.51)

1.53 (1.11–2.17)

1.20 (0.91–1.79)

1.92 (1.24–2.79)

 < 0.001

Low-density lipoprotein cholesterol (mmol/L)b

2.67 ± 0.97 (n = 1009)

2.76 ± 0.98

2.47 ± 0.87

2.91 ± 1.17

2.74 ± 0.95

 < 0.001

Serum calcium (mmol/L)b

2.12 ± 0.28 (n = 1013)

2.13 ± 0.28

2.09 ± 0.31

2.11 ± 0.23

2.16 ± 0.24

0.077

Serum phosphorus (mmol/L)b

1.66 ± 0.67 (n = 1013)

1.65 ± 0.59

1.77 ± 0.70

1.50 ± 0.48

1.43 ± 1.04

 < 0.001

Serum potassium (mmol/L)b

4.11 ± 0.85 (n = 1013)

4.12 ± 0.83

4.16 ± 0.81

4.12 ± 0.96

3.82 ± 0.97

0.019

IPTH (pg/mL)c

31.40 (12.25–93.56, n = 552)

32.45 (12.05–106.45)

32.90 (14.50–98.00)

31.40 (14.20–97.35)

17.10 (5.98–63.10)

0.073

Statins [n (%)]

145 (14.3%, n = 1013)

56 (11.9%)

39 (10.4%)

33 (34.7%)

17 (23.6%)

 < 0.001

Peritonitis [n (%)]

301 (29.7%, n = 1013)

153 (32.4%)

87 (23.3%)

31 (32.6%)

30 (41.7%)

0.002

  1. Statistically significant results are indicated in bold
  2. HDL-C high-density lipoprotein cholesterol, DM diabetes mellitus, WBC white blood cell, CVD cardiovascular disease, ALT alanine aminotransferase, AST aspartate aminotransferase, iPTH intact parathyroid hormone
  3. aData are expressed as number (%) unless otherwise indicated
  4. bData are expressed as mean ± standard deviation
  5. cData are expressed as median (interquar the range)
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us